Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Indian groups seek new areas as government price ceilings hit profits

Government regulations mean hospitals have been forced to cut their charges for drugs and devices in that cardiology and orthopaedics. Pacemakers are to be hit next, with falls of 50-70% in pricing. These price cuts apply even for wealthy private patients paying cash. Small wonder the largest player, Apollo Hospitals, is down 29% on the year with Fortis off 18%. So how are Indian hospital groups reacting?

Healthcare Europa Sept 2017

This September, we bring you the complete picture of dentistry in Europe as consolidation speeds-up, cover medical education and have in-depth interviews with leaders in medical education, digital health, venture capital, healthcare property and operators from Norway and Hungary. In news, we have plenty of deals, look at the changing insurance market and examine what went wrong in Falck.

Capio buys Norwegian ophthalmology chain

Listed Swedish healthcare provider Capio has bought its third ophthalmology operator in a year, acquiring Norwegian company Orbita. We speak to Capio about the deal and look at how private hospitals are moving from inpatient to outpatient.

Interview: Nico de Waal, CEO, PSG Alpha

South African investor PSG Alpha took a 50% stake in nursing home group Evergreen Lifestyle for US$50m this month. The elderly care opportunity in the country is huge, says CEO Nico De Waal, but the problem is knowing where to start with precious little to consolidate.

FREE BLOG Old and obese: Health insurers must adapt or die

“Fat, 65-year-old gentlemen who don’t realise they have a huge problem.” That was one speaker’s description of insurers at last week's Global Health Insurance Conference in Amsterdam. Worryingly, most of the delegates agreed they had a problem. 

Advent sells its shares in Fleury

Private equity firm Advent International has sold all of its shares in Fleury S.A, the second-largest diagnostic laboratory group in Brasil, pocketing 1.3 billion real ($408m).

Find Us